BTL Emsella Chair

• Product: Emsella
• Category: Medical aesthetic device
• Product type: Non-invasive electromagnetic pelvic floor stimulator
• Primary application: Pelvic floor muscle stimulation and rehabilitation
• Intended use: Treatment of male and female urinary incontinence, according to the applicable regulatory documentation
• Treatment: Non-invasive; electromagnetic stimulation
• Patient position: Seated on the treatment chair
• Product condition: Seller to specify

Emsella should not be confused with other BTL electromagnetic or muscle-conditioning systems. The specific model and regulatory documentation should be checked against the serial number of the machine being sold.

• Non-invasive electromagnetic stimulation of the pelvic floor musculature.
• Designed to stimulate pelvic floor muscles while the patient remains seated.
• Intended for rehabilitation of weak pelvic muscles.
• Designed to support restoration of neuromuscular control.
• Regulatory documentation identifies treatment of urinary incontinence in both male and female patients for the applicable device configuration.
• No invasive electrodes or probes are required for the electromagnetic treatment.
• What's included: Exact chair configuration, control system, accessories and supplied components should be confirmed with the seller.

Suitable for professional medical, physiotherapy, urology and aesthetic clinics offering pelvic floor rehabilitation and urinary incontinence treatment, subject to local regulations, practitioner qualifications and the indications applicable to the specific device.

BTL is an international medical technology manufacturer producing equipment across areas including physiotherapy, rehabilitation, urology, aesthetics and medical treatment. BTL Industries is identified as the manufacturer/applicant for Emsella-related regulatory submissions in the US.

FDA records identify Emsella as an electrical, non-implantable stimulator for incontinence. BTL's more recent pelvic-floor device BTL-398 received FDA 510(k) clearance K241516, with the BTL HPM-6000UF identified as its predicate device.

Important: FDA clearance for a particular BTL device or later model should not automatically be treated as certification for every Emsella unit. UKCA/CE status for the individual Emsella machine being advertised could not be independently verified from the public sources reviewed. Buyers should request the relevant Declaration of Conformity and UK regulatory documentation for the exact unit.

Emsella is a dedicated BTL pelvic-floor stimulation system rather than a modular laser or IPL platform. No specific external treatment-platform compatibility could be verified from the manufacturer's publicly available information reviewed.

Replacement parts, control components and accessories should be checked against the exact Emsella model and serial number before purchase.

What is BTL Emsella used for?

Emsella is designed to provide non-invasive electromagnetic stimulation of the pelvic floor muscles for rehabilitation of weak pelvic muscles and restoration of neuromuscular control in the treatment of urinary incontinence.

How does Emsella work?

The system uses electromagnetic stimulation to induce pelvic floor muscle contractions without requiring invasive electrodes or probes.

Is Emsella invasive?

No. The regulatory description identifies the treatment as entirely non-invasive electromagnetic stimulation.

Can Emsella be used for male and female patients?

The relevant BTL regulatory documentation identifies treatment of urinary incontinence in both male and female patients.

Does the patient need to remove their clothing?

The Emsella system is designed as a seated, non-invasive treatment, but the exact treatment protocol should be confirmed against the manufacturer's instructions for use.

What should I check when buying a pre-owned Emsella?

Check the exact model and serial number, service history, operating condition, treatment chair, control system, electrical requirements and available manufacturer documentation. Also request evidence of applicable UK compliance.

Is Emsella the same as other BTL muscle-stimulation devices?

No. BTL produces several electromagnetic and muscle-stimulation systems with different intended uses. Buyers should verify the exact model rather than applying specifications from another BTL device.

Is Emsella FDA cleared?

FDA records identify Emsella as an electrical, non-implantable stimulator for incontinence, while subsequent BTL pelvic-floor systems have separate 510(k) submissions. The regulatory status should therefore be checked against the exact model being purchased.